Related Experiment Video
Updated: Aug 31, 2025
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
Ambra1 in cancer: implications for clinical oncology
Yan-Qiu Qin1, Si-Yu Liu1, Mei-Ling Lv1
1Department of Medical Oncology, The Second Affiliated Hospital of Guangxi Medical University, No. 166 Daxuedong Road, Nanning, 530007, Guangxi, People's Republic of China.
Abstract:
Activating molecule in Beclin-1-regulated autophagy protein 1 (Ambra1) is well known to mediate the autophagy process and promote the formation of autophagosomes. In addition, Ambra1 is involved in the execution of apoptosis. A growing number of studies have revealed that this protein modifies the sensitivity of cancer cells to anticancer drugs by controlling the balance between autophagy and apoptosis. In addition, Ambra1 is a key factor in regulating the cell cycle, proliferation, invasion and migration. Therefore, it plays a key role in tumorigenesis and progression. Moreover, Ambra1 is highly expressed in a variety of cancers and is closely related to the prognosis of patients. Thus, it appears that Ambra1 has multiple roles in tumorigenesis and progression, which may have implications for clinical oncology. The present review focuses on recent advances in the study of Ambra1, especially the role of the protein in tumorigenesis, progression and effects on anticancer drug sensitivity.
Insights
Activating molecule in Beclin-1-regulated autophagy protein 1 (Ambra1) regulates autophagy, apoptosis, and cell cycle, impacting cancer progression and drug sensitivity. Understanding Ambra1 is crucial for developing novel cancer therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Activating molecule in Beclin-1-regulated autophagy protein 1 (Ambra1) is a key regulator of autophagy and apoptosis.
- Ambra1 influences cancer cell sensitivity to anticancer drugs by balancing autophagy and apoptosis.
- This protein also plays a critical role in cell cycle control, proliferation, invasion, and migration.
Purpose of the Study:
- To review recent advances in understanding the multifaceted roles of Ambra1.
- To highlight Ambra1's involvement in tumorigenesis and cancer progression.
- To discuss the impact of Ambra1 on anticancer drug sensitivity.
Main Methods:
- Literature review of recent studies on Ambra1.
- Analysis of Ambra1's molecular functions in cancer.
- Synthesis of findings related to Ambra1's clinical implications.
Main Results:
- Ambra1 is highly expressed in various cancers, correlating with patient prognosis.
- Ambra1 significantly affects cancer cell behavior, including proliferation and metastasis.
- Modulation of Ambra1 impacts the efficacy of cancer treatments.
Conclusions:
- Ambra1 is a critical factor in tumorigenesis and progression across multiple cancer types.
- Ambra1's dual role in autophagy and apoptosis offers potential therapeutic targets.
- Further research into Ambra1 could lead to improved clinical oncology strategies.
Related Concept Videos
01:21Cancer Survival Analysis
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:56Treatment Resistant Cancers
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:18Cancer